Literature DB >> 8032335

A controlled clinical, electromyographic, and kinesiographic assessment of craniomandibular disorders in women.

P Tsolka1, M R Fenlon, A J McCullock, H W Preiskel.   

Abstract

Clinical, electromyographic, and kinesiographic methods were used to evaluate 35 female patients presenting with craniomandibular disorders. Twenty-six similarly aged, symptom-free women served as controls. Clinical assessments showed that the patients demonstrated a higher prevalence of bruxism than did the controls. Electromyographic results suggested that the rest activity of patients' elevators was significantly greater than that of the controls. Kinesiographic measurements showed that the patient group demonstrated greater vertical and anterior posterior movements from rest to centric occlusion than did the control group, and both the average and maximum opening velocities were smaller in patients than in controls.

Entities:  

Mesh:

Year:  1994        PMID: 8032335

Source DB:  PubMed          Journal:  J Orofac Pain        ISSN: 1064-6655


  3 in total

Review 1.  Clinical and experimental aspects of temporomandibular disorders.

Authors:  P Svensson; L Arendt-Nielson
Journal:  Curr Rev Pain       Date:  2000

Review 2.  Efficacy of Kinematic Parameters for Assessment of Temporomandibular Joint Function and Disfunction: A Systematic Review and Meta-Analysis.

Authors:  Alessandra Scolaro; Shahnawaz Khijmatgar; Pooja Mali Rai; Francesca Falsarone; Francesca Alicchio; Arianna Mosca; Christian Greco; Massimo Del Fabbro; Gianluca Martino Tartaglia
Journal:  Bioengineering (Basel)       Date:  2022-06-22

3.  Influence of temporomandibular disorder on temporal and masseter muscles and occlusal contacts in adolescents: an electromyographic study.

Authors:  Leandro Lauriti; Lara Jansiski Motta; Camila Haddad Leal de Godoy; Daniela Aparecida Biasotto-Gonzalez; Fabiano Politti; Raquel Agnelli Mesquita-Ferrari; Kristianne Porta Santos Fernandes; Sandra Kalil Bussadori
Journal:  BMC Musculoskelet Disord       Date:  2014-04-10       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.